-
Anna Vod
- February 27, 2024
Freenome scores $254M to advance its cancer-detection blood tests
The San Francisco company readies to reveal its first clinical study results in the near term
Read MoreThe San Francisco company readies to reveal its first clinical study results in the near term
Read More